Excellent hemostatic control during cardiac surgery in a patient with hemophilia B treated with albutrepenonacog alfa (rIX-FP): A case report.
Francisco-José López-JaimeIhosvany Fernández BelloEva Calavia-ArandaBegoña Reina-MonsóAdrián MontañoPublished in: Clinical case reports (2023)
Cardiac surgery poses a high hemostatic risk in patients with hemophilia. We present the first case of an adult patient with hemophilia B on treatment with albutrepenonacog alfa (rIX-FP) who underwent surgery for acute coronary syndrome. Treatment with rIX-FP made it possible to perform the surgery safely.